$952 Sandvik Coromant RA245-203R63-12L CoroMill 245 Face Milling Cutt Industrial Scientific Cutting Tools Sandvik,$952,Coromant,Face,RA245-203R63-12L,Cutt,Industrial Scientific , Cutting Tools,CoroMill,245,Milling,americapropertysource.com.au,/blinter6640045.html Sandvik Coromant RA245-203R63-12L CoroMill Max 83% OFF Cutt Face Milling 245 Sandvik Coromant RA245-203R63-12L CoroMill Max 83% OFF Cutt Face Milling 245 Sandvik,$952,Coromant,Face,RA245-203R63-12L,Cutt,Industrial Scientific , Cutting Tools,CoroMill,245,Milling,americapropertysource.com.au,/blinter6640045.html $952 Sandvik Coromant RA245-203R63-12L CoroMill 245 Face Milling Cutt Industrial Scientific Cutting Tools

Sandvik Coromant RA245-203R63-12L CoroMill Safety and trust Max 83% OFF Cutt Face Milling 245

Sandvik Coromant RA245-203R63-12L CoroMill 245 Face Milling Cutt

$952

Sandvik Coromant RA245-203R63-12L CoroMill 245 Face Milling Cutt

Product description

Sandvik CoroMill 245 light cutting face mill for heavy roughing and mirror finishing. Milling cutter for high metal removal and mirror finish. The cutter is designed with enhanced corners to reduce burr formation and frittering of the component. Arbor, CIS arbor, cylindrical shank, whistle notch/weldon mounting. Available in an exchangeable cassette system, a concept for rough to semi-finishing of steel. Easy to use and high productivity. Light cutting with low power consumption. Close tolerance combined with the wiper insert for superior surface finish. Wide range of grades and geometries including ceramic and CBN grades. Application: face milling applications in all types of materials, face mill diameter range: 32-250mm, face mill with exchangeable cassette: 160-500mm. ISO application area: steel, stainless steel, cast iron, aluminum, heat resistant and titanium alloys, hardened material.

Sandvik Coromant RA245-203R63-12L CoroMill 245 Face Milling Cutt

Opinion

BL Ink

Multimedia

Resources

Portfolio allocation of the cabinet reshuffle

Increase gap between Covishield doses to 12-16 weeks, says expert govt panel

Expert panel recommends Covaxin Phase II & III trials on 2-18 age group